Vimarsana
Biggest News Aggregation in the World

Page 22 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

ESSA Pharma: Fiscal Q1 Earnings Snapshot -February 13, 2024 at 07:26 am EST - Vimarsana News

ESSA Pharma: Fiscal Q1 Earnings Snapshot -February 13, 2024 at 07:26 am EST

VANCOUVER, British Columbia — VANCOUVER, British Columbia — ESSA Pharma Inc. on Tuesday reported a loss of $6 million in its fiscal first quarter. On a per-share basis, the Vancouver,...

Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month Why Repare Therapeutics Stock Is Tumbling Today - Repare Therapeutics (NASDAQ:RPTX), Roche Holding (OTC:RHHBY) - Vimarsana News

Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month Why Repare Therapeutics Stock Is Tumbling Today - Repare Therapeutics (NASDAQ:RPTX), Roche Holding (OTC:RHHBY)

Repare Therapeutics regains global rights to camonsertib (RP-3500) after terminating collaboration with Roche. $40M milestone achieved.

Acasti Pharma (NASDAQ:ACST) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS - Vimarsana News

Acasti Pharma (NASDAQ:ACST) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Acasti Pharma (NASDAQ:ACST – Get Free Report) announced its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Performance ACST stock opened at $2.61 on Tuesday. Acasti Pharma has a one year low […]

Acasti Pharma (NASDAQ:ACST) Releases Earnings Results - Vimarsana News

Acasti Pharma (NASDAQ:ACST) Releases Earnings Results

Acasti Pharma (NASDAQ:ACST – Get Free Report) released its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Up 6.5 % Shares of NASDAQ ACST opened at $2.61 on Tuesday. The firm has a market cap […]

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights - Vimarsana News

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

MEI Pharma, Inc. , a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today reported results for the...